The Latest on Mifepristone

Today's episode is an absolute must-listen to. The FDA's decision to approve the drug, Mifepristone, has been escalated in a lawsuit to the U.S. Supreme Court. And, last week, in a unanimous 9-0 decision, the U.S. Supreme Court rejected the challenge to the drug's approval. Today on our podcast, we are answering what exactly is happening with the drug Mifepristone, the legal challenges associated with this medication, and how this U.S. Supreme Court ruling directly impacts pharmacists today.Regardless of your position on this topic, knowing and understanding the history and why the mifepristone conversation is happening is critical.By the time you finish listening, you'll be inspired to take immediate action to join your local and state-level pharmacy association. For more resources, including links to the discussions, education, and training mentioned in the episode, click here to learn more. The GameChangerPharmacists should understand legal boundaries and ethical considerations surrounding medications like mifepristone to provide safe, compliant, and patient-centered care. GuestDavid Brushwood, RPh, JDSenior LecturerUniversity of Wyoming ReferenceSupreme Court Document on RulingSupreme Court preserves access to abortion pill Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the historical context and legal evolution of mifepristone regulation by the FDA, including key changes and their implications for pharmacy practice.2. Identify the ethical responsibilities and state and federal legal requirements when dispensing medications such as mifepristone.0.05 CEU/0.5 HrUAN: 0107-0000-24-209-H03-PInitial release date: 06/24/2024Expiration date: 06/24/2025Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram